Quarterly report pursuant to Section 13 or 15(d)

Share-based Compensation (Tables)

v3.21.1
Share-based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Stock Options and Grants [Abstract]  
Schedule of stock-based compensation expense included in statement of operations




Three Months Ended
March 31,





2021
2020


Payroll and related expenses

   


$

286,186

   

$

38,764

   

 

       Total

   


$

286,186

   

$

38,764

   





Three Months Ended
March 31,





 2021

2020

 

Stock options

   


$

2,666

  

  

$

2,667

   

 

Restricted Stock Units 

   


 

283,520

  

  

 

36,097

   


Total

$ 286,186

$ 38,764
Summary of employee stock option activity

 

 

 Shares

 

 

Weighted Average Fair Value Per Share

 

 

Weighted
Average Exercise Price Per Share

 

 

Weighted Average Remaining Terms (in years)

 

 

Aggregate Intrinsic Value

 


Outstanding – December 31, 2020

 

 

36,437

 

 

$

35.54

 

 

$

78.71

 

 

 

6.34

 

 

$

 


Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Exercised 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Cancelled

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Outstanding – March 31, 2021

 

 

36,437

 

 

 

24.80

 

 

 

78.71

 

 

 

6.09

 

 

$

 


Exercisable – December 31, 2020

 

 

36,332

 

 

 

24.80

 

 

 

78.67

 

 

 

6.34

 

 

 

 


Exercisable – March 31, 2021

 

 

36,437

 

 

$

24.80

 

 

$

78.71

 

 

 

6.09

 

 

$

 

Schedule of RSU activities


Number of Shares

 

Non-vested balance at January 1, 2021



527,504

 

Granted





Vested

Forfeited/Expired

Non-vested balance at March 31, 2021
527,504